Retrospective Analysis of Clinical and Cost Outcomes Associated with Methicillin-Resistant <i>Staphylococcus aureus</i> Complicated Skin and Skin Structure Infections Treated with Daptomycin, Vancomycin, or Linezolid

<table>Mean duration of antibiotic therapy.</table>

Journal of Pathogens

fig1

Figure 1

Figure 1: Retrospective Analysis of Clinical and Cost Outcomes Associated with Methicillin-Resistant <i>Staphylococcus aureus</i> Complicated Skin and Skin Structure Infections Treated with Daptomycin, Vancomycin, or Linezolid 

Figure 1 | Retrospective Analysis of Clinical and Cost Outcomes Associated with Methicillin-Resistant Staphylococcus aureus Complicated Skin and Skin Structure Infections Treated with Daptomycin, Vancomycin, or Linezolid 